Principal Financial Group Inc Theravance Biopharma, Inc. Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$8.22 - $11.59 $13,826 - $19,494	-1,682 Reduced 10.26%	14,708 $131,000
Q4 2023 Feb 07, 2024	SELL	$8.58 - $11.4 $19,279 - $25,615	-2,247 Reduced 12.06%	16,390 $184,000
Q3 2023 Nov 02, 2023	BUY	$8.38 - $10.44 $14,782 - $18,416	1,764 Added 10.45%	18,637 $160,000
Q2 2023 Aug 07, 2023	SELL	$10.16 - $11.92 $5,791 - $6,794	-570 Reduced 3.27%	16,873 $174,000
Q1 2023 May 09, 2023	SELL	$9.87 - $11.44 $10,975 - $12,721	-1,112 Reduced 5.99%	17,443 $189,000
Q4 2022 Feb 09, 2023	BUY	$9.65 - $11.34 $7,999 - $9,400	829 Added 4.68%	18,555 $208,000
Q3 2022 Nov 09, 2022	BUY	$8.39 - $10.22 $436 - $531	52 Added 0.29%	17,726 $180,000
Q2 2022 Aug 10, 2022	BUY	$8.41 - $10.34 $60,123 - $73,920	7,149 Added 67.92%	17,674 $160,000
Q1 2022 May 09, 2022	BUY	$8.33 - $12.96 $87,673 - $136,404	10,525 New	10,525 $101,000
Q4 2021 Feb 09, 2022	SELL	$7.42 - $11.05 $184,008 - $274,028	-24,799 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$6.77 - $14.41 $67,354 - $143,365	9,949 Added 67.0%	24,799 $184,000
Q2 2021 Aug 10, 2021	BUY	$14.52 - $22.46 $10,744 - $16,620	740 Added 5.24%	14,850 $215,000
Q1 2021 May 10, 2021	SELL	$16.57 - $21.08 $160,165 - $203,759	-9,666 Reduced 40.65%	14,110 $288,000
Q4 2020 Feb 08, 2021	BUY	$14.89 - $20.16 $181,985 - $246,395	12,222 Added 105.78%	23,776 $422,000
Q3 2020 Nov 06, 2020	SELL	$14.79 - $22.49 $8,459 - $12,864	-572 Reduced 4.72%	11,554 $170,000
Q2 2020 Aug 05, 2020	BUY	$20.64 - $30.69 $71,951 - $106,985	3,486 Added 40.35%	12,126 $255,000
Q1 2020 May 12, 2020	BUY	$17.84 - $31.21 $6,654 - $11,641	373 Added 4.51%	8,640 $200,000
Q4 2019 Feb 05, 2020	BUY	$16.12 - $25.89 $133,264 - $214,032	8,267 New	8,267 $214,000
Q1 2019 May 10, 2019	SELL	$22.57 - $28.15 $178,460 - $222,582	-7,907 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$22.52 - $35.07 $151,447 - $235,845	-6,725 Reduced 45.96%	7,907 $202,000
Q3 2018 Nov 14, 2018	BUY	$22.83 - $32.67 $113,191 - $161,977	4,958 Added 51.25%	14,632 $478,000
Q1 2018 May 14, 2018	BUY	$23.37 - $29.71 $20,285 - $25,788	868 Added 9.86%	9,674 $235,000
Q4 2017 Feb 13, 2018	BUY	$25.82 - $35.66 $6,041 - $8,344	234 Added 2.73%	8,806 $246,000
Q3 2017 Nov 02, 2017	BUY	$23.88 - $34.96 $204,699 - $299,677	8,572	8,572 $294,000

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

Madison Avenue Partners, LP New York, NY

9.51M
Shares

$91.4 Million
9.44% of portfolio
Weiss Asset Management LP Boston, MA

7.46M
Shares

$71.7 Million
1.94% of portfolio
Newtyn Management, LLC New York, NY

4.5M
Shares

$43.2 Million
6.4% of portfolio
Black Rock Inc. New York, NY

3.78M
Shares

$36.3 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$26.5 Million
1.95% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $642M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account